Elevance Health (ELV) Projected to Release Earnings on Wednesday

Elevance Health (NYSE:ELV) is expected to announce its Q3 2026 results before the market opens on Wednesday, October 21st. Analysts expect Elevance Health to announce earnings of $4.71 per share and revenue of $49.29 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Wednesday, October 21, 2026 at 8:30 AM ET.

Elevance Health Stock Up 0.4%

ELV stock opened at $430.06 on Tuesday. The stock has a 50-day simple moving average of $404.84 and a two-hundred day simple moving average of $387.58. Elevance Health has a twelve month low of $274.84 and a twelve month high of $436.24. The firm has a market capitalization of $93.27 billion, a PE ratio of 14.57, a PEG ratio of 2.23 and a beta of 0.70. The company has a quick ratio of 1.52, a current ratio of 1.52 and a debt-to-equity ratio of 0.68.

Analysts Set New Price Targets

ELV has been the topic of several research analyst reports. Sanford C. Bernstein set a $488.00 price target on shares of Elevance Health in a report on Thursday, July 16th. Leerink Partners increased their price objective on Elevance Health from $364.00 to $395.00 and gave the stock a “market perform” rating in a research report on Friday, July 17th. TD Cowen lifted their price objective on Elevance Health from $400.00 to $465.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Barclays lifted their price objective on Elevance Health from $457.00 to $469.00 and gave the company an “overweight” rating in a research note on Wednesday, October 7th. Finally, Wells Fargo & Company reduced their target price on Elevance Health from $492.00 to $473.00 and set an “overweight” rating for the company in a research report on Thursday, July 16th. Fifteen equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $441.71.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a diversified health benefits company that provides health insurance and related services in the United States. Its offerings serve employers, individuals and families, as well as members of government-sponsored programs, including Medicare and Medicaid. The company provides medical, pharmacy, behavioral health and other benefits through a range of health plans and specialty products.

Elevance Health operates its health benefits businesses through a portfolio that includes Blue Cross and Blue Shield-affiliated plans and other insurance offerings.